Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Bionano Genomics Inc (NASDAQ: BNGO) closed at $1.71 down -2.84% from its previous closing price of $1.76. In other words, the price has decreased by -$2.84 from its previous closing price. On the day, 0.55 million shares were traded. BNGO stock price reached its highest trading level at $1.77 during the session, while it also had its lowest trading level at $1.68.
Ratios:
For a deeper understanding of Bionano Genomics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.41 and its Current Ratio is at 1.76. In the meantime, Its Debt-to-Equity ratio is 0.43 whereas as Long-Term Debt/Eq ratio is at 0.14.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $4.Scotiabank initiated its Sector Outperform rating on January 05, 2023, with a $4 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BNGO now has a Market Capitalization of 16553254 and an Enterprise Value of 11145510. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.61 while its Price-to-Book (P/B) ratio in mrq is 0.15. Its current Enterprise Value per Revenue stands at 0.406 whereas that against EBITDA is -0.294.
Stock Price History:
The Beta on a monthly basis for BNGO is 2.24, which has changed by -0.9380435 over the last 52 weeks, in comparison to a change of 0.15101504 over the same period for the S&P500. Over the past 52 weeks, BNGO has reached a high of $30.52, while it has fallen to a 52-week low of $1.50. The 50-Day Moving Average of the stock is -47.03%, while the 200-Day Moving Average is calculated to be -67.62%.
Shares Statistics:
For the past three months, BNGO has traded an average of 504.97K shares per day and 2440230 over the past ten days. A total of 9.68M shares are outstanding, with a floating share count of 7.23M. Insiders hold about 25.33% of the company’s shares, while institutions hold 9.74% stake in the company. Shares short for BNGO as of 1757894400 were 706376 with a Short Ratio of 1.40, compared to 1755216000 on 398382. Therefore, it implies a Short% of Shares Outstanding of 706376 and a Short% of Float of 14.860000000000001.
Earnings Estimates
The market rating for Bionano Genomics Inc (BNGO) is a result of the insights provided by 1.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$2.14, with high estimates of -$2.14 and low estimates of -$2.14.
Analysts are recommending an EPS of between -$7.81 and -$7.81 for the fiscal current year, implying an average EPS of -$7.81. EPS for the following year is -$2.49, with 1.0 analysts recommending between -$2.49 and -$2.49.
Revenue Estimates
A total of 2 analysts believe the company’s revenue will be $6.91M this quarter.It ranges from a high estimate of $7.01M to a low estimate of $6.8M. As of the current estimate, Bionano Genomics Inc’s year-ago sales were $6.07MFor the next quarter, 2 analysts are estimating revenue of $8.36M. There is a high estimate of $8.52M for the next quarter, whereas the lowest estimate is $8.2M.
A total of 2 analysts have provided revenue estimates for BNGO’s current fiscal year. The highest revenue estimate was $28.72M, while the lowest revenue estimate was $28.19M, resulting in an average revenue estimate of $28.45M. In the same quarter a year ago, actual revenue was $30.78MBased on 2 analysts’ estimates, the company’s revenue will be $37.56M in the next fiscal year. The high estimate is $40.62M and the low estimate is $34.5M.
